New grad roles at Kyverna Therapeutics
Kyverna Therapeutics is a clinical-stage biopharmaceutical company developing CAR T-cell therapies for autoimmune diseases. Its pipeline targets conditions such as lupus, multiple sclerosis, systemic sclerosis, stiff person syndrome, and myasthenia gravis.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 11
No current roles
Clear a filter to see every role.
Get new Kyverna Therapeutics new grad roles by email
Free account. Get new Kyverna Therapeutics new grad roles by email or push the minute they post.
